Tawny Allen
Family Medicine · Quincy, ILNPI 1255319844
Payments from drug & device makers
Across 1,024 payments — averaging $13.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AstraZeneca$2K
- AbbVie$1K
- Pfizer$1K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- plus $5K from 29 others
What the payments were for
- Food & beverage$13,90099%
- Education$1231%
- Other$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 178 | $2,658 |
| AstraZeneca | 92 | $1,741 |
| AbbVie(2 entities) | 145 | $1,443 |
| Pfizer | 100 | $1,295 |
| Lilly USA, LLC | 86 | $1,144 |
| Novo Nordisk | 102 | $1,070 |
| Abbott | 34 | $539 |
| Astellas Pharma US Inc | 27 | $521 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $487 |
| Boehringer Ingelheim | 26 | $374 |
| Johnson & Johnson | 32 | $355 |
| Novartis | 20 | $330 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $244 |
| GSK | 15 | $233 |
| Bayer | 11 | $193 |
| Biohaven Pharmaceuticals, Inc. | 29 | $193 |
| Mylan Specialty L.p. | 12 | $187 |
| Kowa Pharmaceuticals America, Inc. | 8 | $121 |
| Sanofi-aventis U.S. LLC | 8 | $120 |
| Axsome Therapeutics, Inc. | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 8 | $101 |
| Phathom Pharmaceuticals, Inc. | 5 | $100 |
| Currax Pharmaceuticals LLC | 7 | $94 |
| Esperion Therapeutics, Inc. | 5 | $77 |
| Merck | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Exact Sciences | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Welch Allyn | 2 | $24 |
| Viatris Specialty LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$126
How this compares
$14,048 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 11 | $63,330 |
| OzempicSemaglutide | 58 | $57,112 |
| EliquisApixaban | 47 | $38,728 |
| MounjaroTirzepatide | 28 | $29,725 |
| FarxigaDapagliflozin Propanediol | 34 | $28,700 |
| JardianceEmpagliflozin | 21 | $26,192 |
| Xtampza ErOxycodone Myristate | 12 | $22,850 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $21,428 |
| XareltoRivaroxaban | 14 | $19,014 |
| MyrbetriqMirabegron | 14 | $18,005 |
| LinzessLinaclotide | 14 | $13,571 |
| Repatha SureclickEvolocumab | 13 | $12,755 |
| OxycontinOxycodone Hcl | 12 | $11,998 |
| TrulicityDulaglutide | 12 | $10,180 |
| Spiriva RespimatTiotropium Bromide | 19 | $9,953 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $2,658 | $63,33011 claims |
| Novo NordiskOzempic | $1,070 | $57,11258 claims |
| PfizerEliquis, Paxlovid | $1,295 | $40,17263 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,144 | $39,90640 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,741 | $37,48048 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $374 | $36,14540 claims |
| GSKTrelegy Ellipta | $233 | $21,42827 claims |
| Johnson & JohnsonXarelto | $355 | $19,01414 claims |
| Astellas Pharma US IncMyrbetriq | $521 | $18,00514 claims |
| AbbVieLinzess, Synthroid | $1,443 | $15,77438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Quincy
- Divya BatraQuincy$444K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.